When surgeons remove a kidney tumor, they face a delicate balancing act: cut away the cancer while preserving as much of the ...

HUTCHMED (China) Limited (“ HUTCHMED ” or the “Company”) (Nasdaq/AIM:HCM; HKEX:13) today announces that it has initiated the Phase Ia part of a global clinical trial of HMPL-A830 in patients with ...

When the FLAURA2 trial made headlines by showing that adding chemotherapy to the targeted drug osimertinib extended overall ...

MET-driven progression is associated with poor prognosis, and there remains a significant unmet need for effective and well-tolerated treatment options in this setting. Patients were prospectively ...

Leader in targeted immuno-oncology drug development brings three decades of academic and biopharmaceutical oncology expertiseSOUTH SAN FRANCISCO, ...

Immunome plans a Phase 1 trial of IM-1340 in advanced solid tumours in the fourth quarter of 2026 after FDA IND clearance.

Real-World Data Link Earlier Molecular Testing to Longer Survival / ALK, biomarkers, EGFR, first-line therapy, Genomic ...

Genomic testing in high-risk prostate cancer remains underutilized nationally, driven by fragmented ordering and interpretive ...

Can ctDNA Detect Cancer Recurrence Before Scans? / Breast Cancer, cancer blood test, cancer monitoring, cancer ...

India needs a five-year roadmap to expand access to genomic testing and targeted cancer therapies for lower-income patients, ...

Hello, nursing students and young nurses. Have you ever been unsure how to evaluate, provide a rationale for documenting, or give guidance when you find a small wound on the foot of a patient with ...